Treatment of 15 Patients with Hypertension Accompanied by Coronary Heart Disease with Combination of Isosorbide Mononitrate and Levamlodipine

Article Contents

Article Navigation > Journal of Kunming Medical University > 2011 > 32(09):

Treatment of 15 Patients with Hypertension Accompanied by Coronary Heart Disease with Combination of Isosorbide Mononitrate and Levamlodipine[J]. Journal of Kunming Medical University, 2011, 32(09).

Citation:

Treatment of 15 Patients with Hypertension Accompanied by Coronary Heart Disease with Combination of Isosorbide Mononitrate and Levamlodipine[J]. Journal of Kunming Medical University, 2011, 32(09).

Treatment of 15 Patients with Hypertension Accompanied by Coronary Heart Disease with Combination of Isosorbide Mononitrate and Levamlodipine[J]. Journal of Kunming Medical University, 2011, 32(09).

Citation:

PDF( 0 KB)

Treatment of 15 Patients with Hypertension Accompanied by Coronary Heart Disease with Combination of Isosorbide Mononitrate and Levamlodipine

Abstract

Abstract

Objective To observe the clinical effect of combination of isosorbide mononitrate and levamlodipine on hypertension accompanied by coronary heart disease.Methods 30 patients with hypertension accompanied by coronary heart disease were randomly divided into 2 groups:control group and therapy group,15 patients in each group.Patients in both groups received 2.5 mg/d of levamlodipine,and patients in therapy group were also given 60 mg/d of isosorbide mononitrate,the treatment for both groups lasted for 24 weeks...
- Levamlodipine,
- Isosorbide mononitrate,
- Blood pressure

FullText(HTML)

References(0)

References

Relative Articles(2)

Relative Articles

[1]	Weiqiang ZHANG, Fang LUO, Chunhua ZHU, Dezhi TANG. Analysis of Correlations of Age，Diseases and Blood Pressure Based on a Population of 82782 Individuals. Journal of Kunming Medical University, 2023, 44(10): 107-113. doi: 10.12259/j.issn.2095-610X.S20231003
[2]	Yanfei WANG, Juan MA, Yunqiao YANG. Clinical Efficacy and Safety of Sacubatril Valsartan in Patients with Reduced Ejection Fraction Combined with Hypotensive Heart Failure. Journal of Kunming Medical University, 2022, 43(11): 136-140. doi: 10.12259/j.issn.2095-610X.S20221117